The need for preclinical testing expertise is growing as molecular complexity increases.
Daniel Radiloff
Advertisement
Daniel Radiloff, PhD, is director of Business Development, Pacific BioLabs.
Articles by Daniel Radiloff
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Everything to Know About Cell and Gene Therapy in 2025
2
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
3
CGT Innovations: The Three-Pronged Strategy for Industry Growth (Part 2)
4
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
5
